Join our study and receive new potential treatment, free of charge!
This study aims to assess the safety and effectiveness of Gepotidacin (a potential new antibiotic) in treating N. gonorrhoea infections compared to the current standard treatment of ceftriaxone & azithromycin. You will be randomly assigned to receive either Gepotidacin or ceftriaxone & azithromycin. You will be seen by one of our doctors throughout the study for confidential and free of charge consultations.
Body weight > 45kg
Have had urethral discharge up to 14 days past sexual contact with a partner with a confirmed gonorrhoea infection.
Willing to abstain from sexual intercourse or use condoms for all forms of intercourse at the Baseline Visit through to Test-of-Cure Visit
Be in general, good health
Baseline Visit: You will have a blood draw, urine sample collection, ECG & a urethral swab (with or without throat and rectal swabs), and receive the randomised treatment
Test of Cure Visit: Return to the clinic 4-8 days after treatment for a physical exam, assessment of medications and any adverse events and to repeat swabs.
Follow-Up Visit: Based on your results, you may either return to the clinic for swabs or have a phone consult to conclude the study.
If you are interested in joining this study, please contact us using the form below.
Patients will be reimbursed for food and travel once enrolled on the study.